13G Filing: Camber Capital Management and Amag Pharmaceuticals Inc. (AMAG)

Published on May 15, 2017 at 1:10 pm by Insider Monkey Staff in Hedge Funds

Page 1 of 6

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name	Sole Voting Power	Shared Voting Power	Sole Dispositive Power	Shared Dispositive Power	Aggregate Amount Owned Power	Percent of Class
Camber Capital Management	0	2,500,000	0	2,500,000		Camber%
Stephen DuBois Not applicable	0	2,500,000	0	2,500,000		Stephen%

Stephen Dubois

Camber Capital Management

Page 1 of 6 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE
COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of
1934

AMAG Pharmaceuticals,
Inc.

(Name of
Issuer)

Common Stock, par value $0.01 per
share

(Title of Class of
Securities)

00163U106

(CUSIP
Number)

May 04, 2017

(Date of Event
Which Requires Filing of this Statement)

Check the
appropriate box to designate the rule pursuant to which this
Schedule is filed:

☐ Rule
13d-1(b)

☒
Rule
13d-1(c)

☐ Rule
13d-1(d)

*The remainder of
this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover
page.

The information
required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise
subject to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the
Notes).

Persons who respond to the collection of
information contained in this form are not
required to respond unless the form displays a currently valid OMB
control number.

Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)

Page 1 of 6

Next >>